Skip to content
Menu

Novartis AG NVS

Full chart Compare
Set alert

Price alert · NVS

All alert types
150.47 USD -0.75 (-0.50%)

Regular-session close

150.00 -0.47 -0.31%

After hours · Nov 20, 7:17 PM ET

150.24 Day range 152.70
124.36 52-week range 168.62
YTD
+9.14%
1 year
+21.00%

Revenue & Expenses

Revenue Profit Costs
Gross Profit$42.98BCost of Revenue$13.70BNet Income$13.98BSelling, General & Admin$13.25BResearch & Development$11.20BOther Operating Expenses$883.00MInterest Expense$1.14BOther Expenses$131.00MIncome Tax$2.38BRevenue$56.67B

Latest period ending Dec 31, 2025 · select a line to chart its full history

NVS annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
56.67B51.72B46.66B43.46B43.97B
42.98B38.90B34.19B31.88B32.24B
17.64B14.54B9.77B7.95B10.06B
13.98B11.94B14.85B6.96B24.02B
7.155.877.103.1710.63
NVS annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
11.44B11.46B13.39B7.52B12.41B
110.95B102.25B99.94B117.45B131.79B
64.40B58.12B53.20B58.03B63.97B
35.46B31.40B26.44B27.96B31.09B
46.13B44.05B46.67B59.34B67.66B
NVS annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
19.14B17.62B14.46B14.24B15.07B
-4.88B-7.51B5.60B1.47B4.21B
-14.87B-11.74B-14.28B-20.56B-16.26B
-1.53B-1.28B-823.00M-758.00M-855.00M
-24.00M-1.93B5.88B-4.89B2.75B